Results per Page:
Showcasing new strides in rare cancer research
Fred Hutch 4th Rare Cancers Symposium features local and national experts in critical research areas including immunotherapy, clinical trial design and biobanking
Brandeis University honors Fred Hutch molecular biologist
Dr. Steven Henikoff receives 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research
Why do we need to culture cancer cells in fetal cow blood?
From Sullivan Lab, Human Biology Division
A disease driver of pancreatic cancer reveals a new Achilles heel
From the Kugel and Hsieh Labs, Basic Sciences and Human Biology Divisions
Dr. Yeon Soo Kim receives NIH Pathway to Independence Award
Hsieh Lab postdoctoral fellow studies how advanced prostate cancer evades therapy by altering the way RNA builds proteins
Fred Hutch study finds new life for ‘ineffective’ drugs
Innovative method using more authentic tumor samples reveals untapped potential for drugs written off by more conventional tests
Inside every patient, a universe
From the Haffner Lab, Human Biology Division
Conducting RNA reconnaissance
Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium